Rajendra Prasad Dash1, Biswajit Mishra2
BACKGROUND: Congenital vascular malformation is stressful both to the patient and the treating physician. Use of sclerosing agent followed by surgical excision has been used by many. In our study we have used percutaneous injection of N-butyl cyanoacrylate (NBCA) in such lesions to make these lesions amenable to easy excision. N Butyl Cyanoacrylate (NBCA) is a rapidly hardening liquid adhesive often referred to as glue. The substance polymerizes immediately on contact with blood or other ionic fluid. Polymerization result in an exothermic reaction that destroys the vessel wall obliterating the entire peripheral feeding vessel. The condensed mass is excised in toto.
STUDY DESIGN: we have conducted a prospective study to evaluate the effectiveness of n butyl cyanoacrylate in the treatment of vascular anomalies. 30 cases were included. The amount of post-operative bleeding, tissue reaction, post-operative complications, and recurrence rate was noted.
RESULT: Post-operative bleeding was minimal, less than 30 ml in our study. There was no tissue reaction. Only one case had post-operative infection. None had any recurrence.
CONCLUSION: N butyl cyanoacrylate is safer and effective sclerosing agent for treatment of vascular malformation.
